Hernández VM, Zárate A, Galván RE

Language: Spanish
References: 14
Page: 450-453
PDF size: 157.33 Kb.

ABSTRACT

Background: Adiponectin is an hormone produced exclusively in adipose tissue, that actively acts in carbohydrate and fat regulation processes.
Objective: To determine adiponectin levels in a women’s group.
Patients and method: Transversal study in 22 amenorrheal women with climacteric symptoms, and without estrogen therapy. There were excluded those with diabetes, hypertension, dislipoproteinemia and obesity. Significant differences among values of adiponectin in perimenopausal and young women during follicular phase of menstrual cycle were analyzed by means of Student t test. Results: Adiponectin concentration in perimenopausal women was 14.1 ± 8.2 µg/mL (M ± SD), without meaningful difference compared with young women.
Conclusions: It wasn’t significant variation in adiponectin levels compared with normal menstrual cycle women. Further studies are necessary to establish adiponectin effect in postmenopause and its relation with the cardiovascular diseases.

REFERENCES

1. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89(2):447-52.

2. Zárate A, Saucedo R, Basurto L. El tejido adiposo: una nueva glándula del sistema endocrino. Ciencia 2007;58(1):69-76.

3. Weyer C, Funahashi T, Tanaka S, Hotta K, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86(5):1930-5.

4. Arita Y, Kihara S, Ouchi N, Takahashi M, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257(1):79-83.

5. Ouchi N, Kihara S, Arita Y, Maeda K, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100(25):2473-6.

6. Okamoto Y, Arita Y, Nishida M, Muraguchi M, et al. An adipocyte- derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32(2):47-50.

7. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221(2):286-9.

8. Hernández-Valencia M, Zárate A. Conceptos recientes en la etiopatogenia de la diabetes gestacional. Ginecol Obstet Mex 2005;73(7):371-7.

9. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: crosssectional and interventional studies. J Clin Endocrinol Metab 2003;88(10):4823-31.

10. Yokota T, Oritani K, Takahashi I, Ishikawa J, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96(5):1723-32.

11. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, et al. The variation of plasma concentrations of novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003;89(6):667.

12. Ryo M, Nakamura T, Kihara S, Kumada M, et al. Adiponectin as a biomarker of the metabolic syndrome. Cir J 2004;68(11):975-81.

13. Tamakoshi K, Yatsuya H, Wada K, Matsushita K, et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clinical Endocrinol (Oxf.) 2007;66(1):65-71.

14. Galván RE, Basurto L, Saucedo R, Campos S y col. Variación de adiponectina en el ciclo menstrual. Ginecol Obstet Mex 2007;75(8):435-8.